Sevoflurane |
A halogenated ether with anesthetic properties; enhances the activity of G… |
10 g |
23996-10 |
More Info
|
Sevoflurane |
A halogenated ether with anesthetic properties; enhances the activity of G… |
25 g |
23996-25 |
More Info
|
Sevoflurane |
A halogenated ether with anesthetic properties; enhances the activity of G… |
5 g |
23996-5 |
More Info
|
Sevoflurane |
A halogenated ether with anesthetic properties; enhances the activity of G… |
50 g |
23996-50 |
More Info
|
SEW2871 |
A potent, selective S1P1 receptor agonist; selective for the S1P1 receptor… |
10 mg |
10006440-10 |
More Info
|
SEW2871 |
A potent, selective S1P1 receptor agonist; selective for the S1P1 receptor… |
25 mg |
10006440-25 |
More Info
|
SEW2871 |
A potent, selective S1P1 receptor agonist; selective for the S1P1 receptor… |
5 mg |
10006440-5 |
More Info
|
SEW2871 |
A potent, selective S1P1 receptor agonist; selective for the S1P1 receptor… |
50 mg |
10006440-50 |
More Info
|
SF11 |
An antagonist of NPY receptor Y2 (IC50 = 0.199 µM); selective for Y2… |
1 mg |
33355-1 |
More Info
|
SF11 |
An antagonist of NPY receptor Y2 (IC50 = 0.199 µM); selective for Y2… |
10 mg |
33355-10 |
More Info
|
SF11 |
An antagonist of NPY receptor Y2 (IC50 = 0.199 µM); selective for Y2… |
5 mg |
33355-5 |
More Info
|
SF1670 |
Inhibits PTEN activity (IC50 = 2 µM), increasing cellular PIP3 level… |
1 mg |
15368-1 |
More Info
|
SF1670 |
Inhibits PTEN activity (IC50 = 2 µM), increasing cellular PIP3 level… |
5 mg |
15368-5 |
More Info
|
SF2523 |
A dual inhibitor of PI3K and BRD4 (IC50s = 16, and 241 and 1,550 nM for PI… |
1 mg |
21638-1 |
More Info
|
SF2523 |
A dual inhibitor of PI3K and BRD4 (IC50s = 16, and 241 and 1,550 nM for PI… |
10 mg |
21638-10 |
More Info
|
SF2523 |
A dual inhibitor of PI3K and BRD4 (IC50s = 16, and 241 and 1,550 nM for PI… |
5 mg |
21638-5 |
More Info
|
SF2523 |
A dual inhibitor of PI3K and BRD4 (IC50s = 16, and 241 and 1,550 nM for PI… |
500 µg |
21638-500 |
More Info
|
SF7-AM |
A cell-trappable fluorogenic probe for the detection of H2S; reaction of t… |
1 mg |
14623-1 |
More Info
|
S-Farnesyl Thioacetic Acid |
A competitive inhibitor of isoprenylated protein methyltransferase (also k… |
1 mg |
63260-1 |
More Info
|
S-Farnesyl Thioacetic Acid |
A competitive inhibitor of isoprenylated protein methyltransferase (also k… |
10 mg |
63260-10 |
More Info
|
S-Farnesyl Thioacetic Acid |
A competitive inhibitor of isoprenylated protein methyltransferase (also k… |
5 mg |
63260-5 |
More Info
|
S-Farnesyl Thioacetic Acid |
A competitive inhibitor of isoprenylated protein methyltransferase (also k… |
50 mg |
63260-50 |
More Info
|
15(S)-Fluprostenol |
(+)-15(R)-Fluprostenol isopropyl ester is a prodrug (Travoprost) which is… |
1 mg |
16787-1 |
More Info
|
15(S)-Fluprostenol |
(+)-15(R)-Fluprostenol isopropyl ester is a prodrug (Travoprost) which is… |
10 mg |
16787-10 |
More Info
|
15(S)-Fluprostenol |
(+)-15(R)-Fluprostenol isopropyl ester is a prodrug (Travoprost) which is… |
5 mg |
16787-5 |
More Info
|
15(S)-Fluprostenol isopropyl ester |
Unnatural C-15 epimer of Travoprost |
1 mg |
16788-1 |
More Info
|
15(S)-Fluprostenol isopropyl ester |
Unnatural C-15 epimer of Travoprost |
10 mg |
16788-10 |
More Info
|
15(S)-Fluprostenol isopropyl ester |
Unnatural C-15 epimer of Travoprost |
5 mg |
16788-5 |
More Info
|
(S)-Flurbiprofen |
The active enantiomer of flurbiprofen (IC50s = 0.48 and 0.47 µM for… |
1 g |
10004207-1 |
More Info
|
(S)-Flurbiprofen |
The active enantiomer of flurbiprofen (IC50s = 0.48 and 0.47 µM for… |
100 mg |
10004207-100 |
More Info
|
(S)-Flurbiprofen |
The active enantiomer of flurbiprofen (IC50s = 0.48 and 0.47 µM for… |
250 mg |
10004207-250 |
More Info
|
(S)-Flurbiprofen |
The active enantiomer of flurbiprofen (IC50s = 0.48 and 0.47 µM for… |
500 mg |
10004207-500 |
More Info
|
sFRP1 (human, recombinant) |
Source: Active recombinant human C-terminal His-tagged sFRP1 expressed in… |
50 µg |
38061-50 |
More Info
|
SGA360 |
A selective modulator of AhR; competitively binds AhR (IC50 = 3 µM);… |
1 mg |
21986-1 |
More Info
|
SGA360 |
A selective modulator of AhR; competitively binds AhR (IC50 = 3 µM);… |
10 mg |
21986-10 |
More Info
|
SGA360 |
A selective modulator of AhR; competitively binds AhR (IC50 = 3 µM);… |
25 mg |
21986-25 |
More Info
|
SGA360 |
A selective modulator of AhR; competitively binds AhR (IC50 = 3 µM);… |
5 mg |
21986-5 |
More Info
|
SGC0946 |
A potent inhibitor of DOT1L (IC50 = 0.3 nM); over 100-fold selective over… |
10 mg |
13967-10 |
More Info
|
SGC0946 |
A potent inhibitor of DOT1L (IC50 = 0.3 nM); over 100-fold selective over… |
25 mg |
13967-25 |
More Info
|
SGC0946 |
A potent inhibitor of DOT1L (IC50 = 0.3 nM); over 100-fold selective over… |
5 mg |
13967-5 |
More Info
|
SGC0946 |
A potent inhibitor of DOT1L (IC50 = 0.3 nM); over 100-fold selective over… |
50 mg |
13967-50 |
More Info
|
SGC3027 |
A prodrug form of the PRMT7 inhibitor SGC8158; converted by intracellular… |
1 mg |
25325-1 |
More Info
|
SGC3027 |
A prodrug form of the PRMT7 inhibitor SGC8158; converted by intracellular… |
10 mg |
25325-10 |
More Info
|
SGC3027 |
A prodrug form of the PRMT7 inhibitor SGC8158; converted by intracellular… |
5 mg |
25325-5 |
More Info
|
SGC707 |
A potent allosteric inhibitor of PRMT3 (IC50 = 50 nM) with >100-fold selec… |
1 mg |
17017-1 |
More Info
|
SGC707 |
A potent allosteric inhibitor of PRMT3 (IC50 = 50 nM) with >100-fold selec… |
10 mg |
17017-10 |
More Info
|
SGC707 |
A potent allosteric inhibitor of PRMT3 (IC50 = 50 nM) with >100-fold selec… |
25 mg |
17017-25 |
More Info
|
SGC707 |
A potent allosteric inhibitor of PRMT3 (IC50 = 50 nM) with >100-fold selec… |
50 mg |
17017-50 |
More Info
|
SGC-CBP30 |
A potent inhibitor of CREBBP and EP300 bromodomains (IC50s = 21-69 and 38… |
10 mg |
14469-10 |
More Info
|
SGC-CBP30 |
A potent inhibitor of CREBBP and EP300 bromodomains (IC50s = 21-69 and 38… |
5 mg |
14469-5 |
More Info
|
SGC-CBP30 |
A potent inhibitor of CREBBP and EP300 bromodomains (IC50s = 21-69 and 38… |
50 mg |
14469-50 |
More Info
|
SGC-CK2-1 |
A CK2α inhibitor (IC50s = 4.2 and 2.3 for the catalytic subunits CK2… |
1 mg |
34103-1 |
More Info
|
SGC-CK2-1 |
A CK2α inhibitor (IC50s = 4.2 and 2.3 for the catalytic subunits CK2… |
10 mg |
34103-10 |
More Info
|
SGC-CK2-1 |
A CK2α inhibitor (IC50s = 4.2 and 2.3 for the catalytic subunits CK2… |
25 mg |
34103-25 |
More Info
|
SGC-CK2-1 |
A CK2α inhibitor (IC50s = 4.2 and 2.3 for the catalytic subunits CK2… |
5 mg |
34103-5 |
More Info
|
SGC-GAK-1 |
A GAK inhibitor (Ki = 3.1 nM); >50-fold selective for GAK over a panel of… |
10 mg |
33229-10 |
More Info
|
SGC-GAK-1 |
A GAK inhibitor (Ki = 3.1 nM); >50-fold selective for GAK over a panel of… |
25 mg |
33229-25 |
More Info
|
SGC-GAK-1 |
A GAK inhibitor (Ki = 3.1 nM); >50-fold selective for GAK over a panel of… |
5 mg |
33229-5 |
More Info
|
SGC-GAK-1 |
A GAK inhibitor (Ki = 3.1 nM); >50-fold selective for GAK over a panel of… |
50 mg |
33229-50 |
More Info
|
SGC2085 (hydrochloride) |
A PRMT4 / CARM1 inhibitor (IC50 = 50 nM); highly selective for PRMT4 / CAR… |
1 mg |
21879-1 |
More Info
|
SGC2085 (hydrochloride) |
A PRMT4 / CARM1 inhibitor (IC50 = 50 nM); highly selective for PRMT4 / CAR… |
10 mg |
21879-10 |
More Info
|
SGC2085 (hydrochloride) |
A PRMT4 / CARM1 inhibitor (IC50 = 50 nM); highly selective for PRMT4 / CAR… |
5 mg |
21879-5 |
More Info
|
SGC2085 (hydrochloride) |
A PRMT4 / CARM1 inhibitor (IC50 = 50 nM); highly selective for PRMT4 / CAR… |
500 µg |
21879-500 |
More Info
|
SGC-iMLLT |
An inhibitor of the YEATS domain-containing proteins MLLT1 and MLLT3; bind… |
1 mg |
28113-1 |
More Info
|
SGC-iMLLT |
An inhibitor of the YEATS domain-containing proteins MLLT1 and MLLT3; bind… |
10 mg |
28113-10 |
More Info
|
SGC-iMLLT |
An inhibitor of the YEATS domain-containing proteins MLLT1 and MLLT3; bind… |
5 mg |
28113-5 |
More Info
|
SGC Probe Set |
Contains a collection of small, drug-like molecules that inhibit or antago… |
1 ea |
17748-1EA |
More Info
|
SGC-SMARCA-BRDVIII |
A pan-family VIII BRD inhibitor; selectively binds to PBRM1 bromodomain 5,… |
1 mg |
33567-1 |
More Info
|
SGC-SMARCA-BRDVIII |
A pan-family VIII BRD inhibitor; selectively binds to PBRM1 bromodomain 5,… |
10 mg |
33567-10 |
More Info
|
SGC-SMARCA-BRDVIII |
A pan-family VIII BRD inhibitor; selectively binds to PBRM1 bromodomain 5,… |
25 mg |
33567-25 |
More Info
|
SGC-SMARCA-BRDVIII |
A pan-family VIII BRD inhibitor; selectively binds to PBRM1 bromodomain 5,… |
5 mg |
33567-5 |
More Info
|
S-Geranylgeranyl-L-glutathione |
A P2RY8 ligand; selectively induces internalization of P2RY8 over S1P2, GP… |
1 mg |
9004116-1 |
More Info
|
S-Geranylgeranyl-L-glutathione |
A P2RY8 ligand; selectively induces internalization of P2RY8 over S1P2, GP… |
10 mg |
9004116-10 |
More Info
|
S-Geranylgeranyl-L-glutathione |
A P2RY8 ligand; selectively induces internalization of P2RY8 over S1P2, GP… |
5 mg |
9004116-5 |
More Info
|
SGI-1027 |
An inhibitor of the DNA methyltransferases DNMT1, DNMT3A, and DNMT3B (IC50… |
1 mg |
11165-1 |
More Info
|